title: Protease inhibitor therapy-associated lipodystrophy, hypertriglyceridaemia and diabetes mellitus.
authors.forename: V A
authors.initials: VA
authors.lastname: Paparizos
authors.forename: K P
authors.initials: KP
authors.lastname: Kyriakis
authors.forename: C
authors.initials: C
authors.lastname: Botsis
authors.forename: V
authors.initials: V
authors.lastname: Papastamopoulos
authors.forename: M
authors.initials: M
authors.lastname: Hadjivassiliou
authors.forename: N G
authors.initials: NG
authors.lastname: Stavrianeas
mesh_terms: D000328:Adult; D003920:Diabetes Mellitus / Q000139:chemically induced*; D004359:Drug Therapy, Combination; D005260:Female; D005500:Follow-Up Studies; D015658:HIV Infections / Q000188:drug therapy*; D017320:HIV Protease Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D015228:Hypertriglyceridemia / Q000139:chemically induced*; D008060:Lipodystrophy / Q000139:chemically induced*; D008297:Male; D012189:Retrospective Studies; D018894:Reverse Transcriptase Inhibitors / Q000009:adverse effects / Q000627:therapeutic use
chemical_list: D017320:HIV Protease Inhibitors; D018894:Reverse Transcriptase Inhibitors